← back to search

Andrea D. Branch

Icahn School of Medicine at Mount Sinai · US
Area of research
Hepatology · Epidemiology
Research interest
Research interests include Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, and HIV-related health complications and treatments.
h-index
42
citations
5,470
works
198
NIH funding
primary concept
email

Recent publications

Abstract 4366745: Artificial Intelligence-Derived Myosteatosis on Coronary Artery Calcium CT Scans Predicts Incident COPD: An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis (MESA)
Circulation 2025cited by 0position: middledoi
Abstract 4369683: AI-driven Measurement of Myosteatosis in Coronary Artery Calcium Scans Predicts Atrial Fibrillation and Heart Failure. An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis (MESA)
Circulation 2025cited by 0position: middledoi
The adverse characteristics of hepatocellular carcinoma in the non-cirrhotic liver disproportionately disadvantage Black patients.
2024cited by 3position: contributordoi
A Prospective Open-Label Dose-Response Study to Correct Vitamin D Deficiency in Cirrhosis.
2024cited by 2position: contributordoi
Abstract 4144067: AI-enabled Cardiac Chambers Volumetry in Coronary Artery Calcium Scans (AI-CAC) vs. ASCVD Pooled Cohorts Equation and PREVENT Risk Scores: The Multi-Ethnic Study of Atherosclerosis
Circulation 2024cited by 0position: middledoi
Imprinted immune abnormalities in liver transplant patients cured of hepatitis C with antiviral drugs.
2024cited by 0position: contributordoi
Comparison of the extent and progression of respiratory and cardiovascular disease in World Trade Center responders to lung screening participants
2024cited by 0position: contributordoi
Single-cell RNA sequencing data identify a conserved population of metallothionein-expressing macrophages that may be ubiquitous in vital human organs.
2024cited by 0position: contributordoi
IL-6/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver disease
Journal of Hepatology 2023cited by 124position: contributordoi
Environmental exposures are important risk factors for advanced liver fibrosis in African American adults.
2023cited by 19position: contributordoi
Association of HSD17B13 and PNPLA3 With Liver Enzymes and Fibrosis in Hispanic/Latino Individuals of Diverse Genetic Ancestries.
2023cited by 14position: contributordoi
Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis.
2023cited by 7position: contributordoi
Modification of the diabetes prevention program for the treatment of nonalcoholic fatty liver disease: A pilot study.
2023cited by 4position: contributordoi
IL-6/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver disease
Journal of Hepatology 2022cited by 130position: middledoi
Liver Cancer Has a Distinctive Profile in Black Patients: Current Screening Guidelines May Be Inadequate.
2022cited by 9position: contributordoi
Hepatocellular carcinoma surveillance, incidence, and tumor doubling times in patients cured of hepatitis C.
2022cited by 8position: contributordoi
African Immigrants in New York City with Hepatitis B-Related Hepatocellular Carcinoma Demonstrate High Morbidity and Mortality.
2022cited by 2position: contributordoi
A Digital Case-Finding Algorithm for Diagnosed but Untreated Hepatitis C: A Tool for Increasing Linkage to Treatment and Cure.
2021cited by 8position: contributordoi
Dose-response relationship between World Trade Center dust exposure and hepatic steatosis.
2021cited by 5position: contributordoi
A comparative study of cirrhosis sub-staging using the Laennec system, Beijing classification, and morphometry.
2021cited by 5position: contributordoi
MRI is the most commonly used imaging modality for HCC screening at a tertiary care transplant center.
2021cited by 4position: contributordoi
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study
Clinical Gastroenterology and Hepatology 2020cited by 251position: middledoi
Escape from planned obsolescence: Hepatitis C, the cirrhotic liver, and clonal expansions.
2020cited by 0position: contributordoi
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma
Gastroenterology 2019cited by 188position: middledoi
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study
Gastroenterology 2019cited by 162position: middledoi
Hepatic steatosis in participants in a program of low-dose CT screening for lung cancer
European Journal of Radiology 2017cited by 25position: middledoi
A Novel Collaborative Community-Based Hepatitis B Screening and Linkage to Care Program for African Immigrants
Clinical Infectious Diseases 2016cited by 50position: middledoi
Frontline Science: HIV infection of Kupffer cells results in an amplified proinflammatory response to LPS
Journal of Leukocyte Biology 2016cited by 48position: middledoi
Correlates of Hypertension in Patients with AIDS in the Era of Highly Active Antiretroviral Therapy
Journal of the International Association of Providers of AIDS Care (JIAPAC) 2013cited by 42position: middledoi
Rapid Progression to Decompensated Cirrhosis, Liver Transplant, and Death in HIV-Infected Men After Primary Hepatitis C Virus Infection
Clinical Infectious Diseases 2012cited by 71position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 4 papers (2020–2024)Ponni Perumalswami · Ann Arbor VA Medical Center2 papers (2016–2017)Fan Zhang · University of Vermont2 papers (2022–2023)Ning Ma · China North Industries Group Corporation (China)2 papers (2023–2024)Rowena Yip · Clinical Trial Investigators2 papers (2023–2024)Artit Jirapatnakul · Cornell University2 papers (2023–2024) · 1 papers (2013–2013) · 1 papers (2016–2016)Hans-Heinrich Hoffmann · Rockefeller University1 papers (2022–2022)Branko Stefanovic · Nationwide Children's Hospital1 papers (2022–2022) · 1 papers (2016–2016)Charles M. Rice · Rockefeller University1 papers (2022–2022)Meena B. Bansal · NIHR Birmingham Biomedical Research Centre1 papers (2016–2016)Adeeb Rahman · Oregon Health & Science University1 papers (2016–2016)Hari Shankar · New York State College of Agriculture & Life Sciences1 papers (2016–2016)Maria Isabel Fiel · Mount Sinai Hospital1 papers (2016–2016)M. Isabel Fiel · Fundación Pública Galega de Medicina Xenómica1 papers (2012–2012) · 1 papers (2017–2017)Douglas T. Dieterich · Icahn School of Medicine at Mount Sinai1 papers (2012–2012)Kim E. Nichols · University of Alabama1 papers (2016–2016)